StoneX (SNEX) director granted 145 restricted shares; now 35,535
StoneX Group Inc. (SNEX) director Steven A. Kass was granted 145 restricted shares of common stock on 10/31/2025 under the Company’s Restricted Stock Program at a stated price of $0.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
StoneX Group Inc. (SNEX) director Steven A. Kass was granted 145 restricted shares of common stock on 10/31/2025 under the Company’s Restricted Stock Program at a stated price of $0.
Following the grant, Kass beneficially owned 35,535 shares, held directly. The restricted shares vest equally on the anniversary in years one, two, and three, aligning compensation with multi-year service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Shares of Common Stock | 145 | $0.00 | $0.00 |
Footnotes (1)
- F1. Acquired through the Company's Restricted Stock Program. Shares vest equally on anniversary in years one, two and three.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction was reported for SNEX?
What is the insider’s relationship to SNEX?
Was this a Form 4 filed by multiple reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.